Mannatech's Ambrotose boosts brain function

30 April 2009

In a recent study, a single one-tablespoon serving of US nutritional firm Mannatech's Ambrotose complex significantly improved visual  discrimination and working memory.

Researchers from Howard University in Washington DC, conducted a  randomized, double-blind, placebo-controlled study investigating the  impact of Mannatech's patented blend of plant saccharides on the brain  function of 62 healthy young adults. According to lead researcher Atiya  Stancil, the results are impressive because they show significant  improvement in the perceptual capabilities of healthy adults, which  indicates that Ambrotose complex can benefit everyone.

Texas-based Mannatech noted that previous double-blind,  placebo-controlled clinical trials have demonstrated that ingestion of  Ambrotose complex can enhance brain waves associated with attention or  alertness, enhance concentration and improve mental reaction time, as  well as improve memory.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight